Canadian Journal of Diabetes Editorial Advisory Board

CANADIAN JOURNAL OF DIABETES

66

Duality of Interest Disclosures 2007 Canadian Journal of Diabetes Editorial Advisory Board

Editor-in-Chief Heather Dean MD • No dualities of interest declared Associate Editors Robyn Houlden MD • Honoraria or consulting fees: Novo Nordisk, AstraZeneca, Eli Lilly, Novartis, sanofi-aventis, Pfizer, GSK, Medtronic • Grant/research support: AstraZeneca, Eli Lilly, Medtronic, Pfizer, GSK Alexandra Jenkins RD PhD • Employment: Director of Research, Glycemic Index Laboratories Inc. Timothy J. Kieffer PhD • Stock shareholder: enGene • Honoraria or consulting fees: Merck Frosst • Grant/research support: enGene, Johnson & Johnson David C.W. Lau MD PhD • Employment: University of Calgary • Membership on advisory panel, standing committee or board of directors: Abbott, AstraZeneca, CIHR, HSFC sanofi-aventis, Eli Lilly, Merck, Pfizer, Servier • Stock shareholder: GSK, Eli Lilly • Member of a board of directors: Canadian Obesity Network • Honoraria or consulting fees: Abbott, AstraZeneca, Bayer, GSK, sanofi-aventis, Eli Lilly, Merck, Pfizer, Novo Nordisk • Grant/research support: AHFMR, Pfizer, AstraZeneca, sanofi-aventis, BMS, Dainippon Pharmaceuticals, Solvay, CIHR, GSK Margaret Lawson MD MSc FRCPC • Membership on advisory panel, standing committee or board of directors: Medtronic Canada’s

Advisory Panel for Insulin Pump Therapy—declined honorarium • Grant/research support: Eli Lilly, sanofi-aventis Sora Ludwig MD FRCPC • Membership on advisory panel, standing committee or board of directors: sanofi-aventis • Honoraria or consulting fees: sanofi-aventis Beth Mitchell PhD CPsych • No dualities of interest declared Breay Paty MD • Membership on advisory panel, standing committee or board of directors: GSK, Medtronic • Honoraria or consulting fees: GSK, Merck Frosst National Editorial Board Geoff Ball PhD RD • No dualities of interest declared Jean-Pierre Chanoine MD PhD • Membership on an advisory panel, standing committee of board of directors: Novo Nordisk • Honoraria or consulting fees: Roche, Novo Nordisk John Dupré MD BM BCh FRCPC FACP • Honoraria or consulting fees: consultant to Transition Therapeutics, MARS, Toronto, ON • Grant/research support: in field GLP-1 therapy in diabetes mellitus

• Honoraria or consulting fees: sanofi-aventis • Grant/research support: GSK Hertzel Gerstein MD MSc FRCPC • Honoraria or consulting fees: GSK, sanofi-aventis, BI, Merck, Novo Nordisk, Eli Lilly • Grant/research support: GSK, sanofiaventis, Merck, NovoNordisk Sabrina Gill MD MPH FRCPC • Honoraria or consulting fees: BHI, Eli Lilly, Novo Nordisk, GSK, sanofi- aventis, Pfizer, Merck, Medtronic, Amgen Linda McCargar PhD RD • Honoraria or consulting fees: Merck, Dairy Farmers of Canada, Beef Information Centre K.M. Venkat Narayan MD MSc MBA FRCP • Grant/research support: Eli Lilly Teik Chye Ooi MD • Stock shareholder: Nutrition Science Group Inc. • Membership on an advisory panel or standing committee or board of directors: Nutrition Science Group Inc. • Honoraria or consulting fees: Solvay, Schering, Merck, Pfizer • Grant/research support: Novo Nordisk, LifeScan, Merck Frosst/ Schering, Liponex Inc., GSK Michael Riddell PhD • No dualities of interest declared

Alun Edwards MB BChir FRCPC • No dualities of interest declared

Baiju Shah MD PhD FRCPC • Stock shareholder: Isotechnika

I. George Fantus MD FRCPC • Membership on an advisory panel or standing committee of board of directors: Solvay Pharma, AstraZeneca

C. Bruce Verchere PhD • Stock shareholder: Amylin • Honoraria or consulting fees: Merck Frosst